Enanta Pharmaceuticals Inc (ENTA)

[willyw]

Kris.
One thing I think that I have noticed is the phenomena that right before conferences.... there is often a buying opportunity. I used to think this was nuts because often preliminary results were known prior, and in many cases the same or substantially similar data gets trotted out and many react to it as though it is new, or suddenly real.
So, inevitably certain stocks surge following conferences.(and often fade right before too) In this case, EASL ends the 14th of April.

I think many wise people just take money off the table and prefer to bet on something that is confirmed, or check out other overlooked competition, but I also think they wait to see what the market thinks, then buy.

In spite of the great data we will see at EASL, some folks will already be looking at the future pan-genotypic treatments.

This may not be bullish for ENTA, but in no way will it affect the earnings over the next few years. I'm pretty confident that ENTA milestone payments will be achieved, NDA's will be applied for and granted, and market share will happen, payors will pay. : )

Perhaps we will see at the fall AASLD conference what the ABT-493 and ABT-530 combo can do.